MANILA, Philippines —  As the world marks World Blood Cancer Day this May, health experts are urging greater awareness of persistent fatigue, frequent infections and other symptoms that are too often dismissed as normal signs of aging. These overlooked warning signs can point to Myelodysplastic Syndromes (MDS) — now more accurately known as Myelodysplastic Neoplasms — a form of blood cancer in which the bone marrow produces abnormal, cancer-like cells. Despite advances in medical understanding, MDS remains largely under-recognized, delaying diagnosis and treatment for many patients.

While the condition is serious, local data indicates it is frequently missed. A landmark 10-year study at Makati Medical Center, which followed 240 patients, revealed that MDS remains “underestimated, underreported, and underdiagnosed” in the Philippines.  The study highlighted a significant hurdle in the patient journey: out of those 240 individuals, only 15% were able to receive advanced laboratory tests like cytogenetic testing. This means that roughly 85% of patients did not receive a full diagnostic evaluation. Without access to these specialized examinations, many Filipinos may be living with the disease undetected. This means they miss the window for early treatment that can help slow the disease’s progression and improve their daily quality of life.

To bridge this gap, healthcare leaders and specialists are uniting to address the critical need for early diagnosis, specialized treatment, and robust industry collaboration. This collective effort is a continuous, vital mission to protect patient health, with World Blood Cancer Day serving as a powerful global spotlight on our daily responsibility to stay vigilant against silent symptoms and advocate for better blood health.

Understanding the “silent” blood disorder

MDS occurs when the bone marrow—the body’s “blood factory”—starts producing “defective” instead of healthy blood cells. In a functional factory, young cells mature and enter the bloodstream to keep us healthy. In MDS, these cells fail to develop properly and die too early, causing a critical shortage of vital blood components. This “factory failure” leads to conditions such as anemia (low red blood cells), leukopenia (low white blood cells), and thrombocytopenia (low platelets). Without enough of these healthy cells to provide energy, fight infections, and stop bleeding, patients often experience the persistent fatigue and easy bruising that characterize the disease.

While MDS can affect individuals of any age, it is most common in adults over 60. The condition typically manifests as prolonged exhaustion and shortness of breath, frequent infections and petechiae (tiny purple or red spots under the skin). Because these signs are subtle, many Filipinos dismiss them as a normal part of aging and delay seeking medical help.

Early consultation and detection is key

Detecting MDS early is vital for improving long-term health outcomes and preventing the disease from progressing unnoticed. A Complete Blood Count (CBC) can reveal hidden abnormalities that warrant further examination. If irregularities are found, primary care physicians typically refer patients to a Hematologist, a specialist in blood disorders who can perform more detailed diagnostic tests, such as a bone marrow aspiration.

“A good doctor must start by reviewing a patient’s full history and conducting a physical exam, because fatigue is very non-specific and can hide many things,” says Dr. Rosalio Torres, founding president of the Philippine College of Hematology and Transfusion Medicine (PCHTM). “Our blood cells have critical functions: red cells carry oxygen, white cells fight infections, and platelets stop us from bleeding. When these are damaged in MDS, patients suffer from shortness of breath, lack of energy, recurrent infections, and easy bruising or bleeding.”

Dr. Torres emphasizes that while the journey can be challenging, there is a path forward. “We now have management and supportive care options available in the Philippines. While these treatments are often long-term and can be resource-intensive, catching the disease early helps us manage costs and care more effectively.”

A journey of resilience

While the path through MDS looks different for every individual, the journey of one of Dr. Torres’ current patients, a Manila-based businessman in his late 70s, offers a look at what is possible with tailored, modern management.

His journey began like many others: months of dealing with vague, exhausting weakness that standard treatments failed to fix, eventually leading him to a hematologist for a confirmatory bone marrow evaluation. Over the years, his battle with MDS was a rollercoaster that spanned standard supportive therapies, a taxing period of escalating blood transfusions, and even an overseas trip for a medical treatment that ultimately left him disappointed. Because of his age, a stem cell transplant was out of the question.

The turning point came when his care team shifted strategy to a targeted management approach to help improve his red blood cell levels. After structured cycles of therapy, his body responded and his reliance on frequent blood transfusions dropped to zero.

Today, managing his condition requires only routine maintenance visits and ongoing therapy to keep his iron levels balanced. Far from being confined to a hospital room, he is actively running his businesses and enjoying his retirement. More than anything, he is thriving in his favorite role yet—spending purposeful days with his first granddaughter.

His story is a reminder that while MDS is a complex, long-term challenge, a diagnosis is not a dead end. While outcomes may vary between patients, with early specialist intervention, a precise look at the disease markers, and access to medical advancements, there is a tangible path to reclaiming a normal life.

A hopeful outlook

The journey toward better care for MDS in the Philippines rests on three essential pillars: heightened public awareness, early consultation, and a strong collaboration between the government, medical societies, and industry partners. While the diagnostic gap remains a challenge, the landscape is changing, and the most powerful tool we have is vigilance.

By monitoring changes in your health and consulting a healthcare professional, individuals take the first proactive step toward a healthier future. As we observe World Blood Cancer Day this May, let us remember that symptoms are the body’s way of asking for help.

For those who wish to understand the condition more deeply, trusted resources like the MDS Foundation offer comprehensive information and support for patients and caregivers alike. Early detection remains the most effective way to identify the disease and secure the specialized care required to help you, or your loved ones, get back to a life full of energy and purpose.

This information is intended for public education only and should not replace consultation with a qualified healthcare professional.